Document Detail


Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.
MedLine Citation:
PMID:  11466624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mutations in FGFR3 have been identified in several tumour types including bladder carcinoma, cervical carcinoma, and multiple myeloma. In bladder carcinoma, we recently identified FGFR3 mutations in 41% of tumours, making this the most frequently mutated putative oncogene identified in bladder cancer to date. We have now investigated the frequency of FGFR3 mutation in a panel of 125 tumours and 13 cell lines from various other organs. We analysed the mutation hotspots in exons 7, 10 and 15 by direct DNA sequencing, and found one mutation in exon 7 (S249C) in 1/28 (3.5%) cervical tumours. Mutations were not detected in stomach, rectum, colon, prostate, ovarian, breast, brain, or renal tumours, nor were they found in any of the cell lines included in this study. We conclude that FGFR3 is commonly mutated in bladder carcinoma and only rarely in cervical carcinoma. Several tumour types appear not to possess any mutations in FGFR3, suggesting that these mutations are important only in the development of certain types of tumour.
Authors:
K Sibley; P Stern; M A Knowles
Related Documents :
16872824 - Multilocus loss of heterozygosity allelotypes identify a genetic pathway associated wit...
20861914 - Tp53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific ...
16222524 - Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origi...
23440864 - Ascertaining the role of taiwan as a source for the austronesian expansion.
9040744 - A novel point mutation in the peripheral myelin protein 22 (pmp22) gene associated with...
17503474 - Cytogenetic and molecular characterization of a2bp1/fox1 as a candidate gene for autism.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncogene     Volume:  20     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-07-23     Completed Date:  2001-08-09     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  4416-8     Citation Subset:  IM    
Affiliation:
ICRF Clinical Centre, St. James's University Hospital, Leeds, LS9 7TF, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma / genetics
DNA, Neoplasm / analysis
Female
Humans
Mutation*
Neoplasms / genetics*
Protein-Tyrosine Kinases*
Receptor, Fibroblast Growth Factor, Type 3
Receptors, Fibroblast Growth Factor / genetics*
Tumor Cells, Cultured
Urinary Bladder Neoplasms / genetics
Uterine Cervical Neoplasms / genetics
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; 0/Receptors, Fibroblast Growth Factor; EC 2.7.10.1/FGFR3 protein, human; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.1/Receptor, Fibroblast Growth Factor, Type 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.
Next Document:  Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.